<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">387</article-id><article-id pub-id-type="doi">10.17650/1726-9776-2014-10-3-95-99</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL CASE</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЙ СЛУЧАЙ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Surgical treatment for progressive prostate cancer: A clinical case</article-title><trans-title-group xml:lang="ru"><trans-title>Клинический случай: хир ургическое лечение прогрессирующего рака предст ательной железы</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Veliev</surname><given-names>E. I.</given-names></name><name xml:lang="ru"><surname>Велиев</surname><given-names>Е. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Golubtsova</surname><given-names>E. N.</given-names></name><name xml:lang="ru"><surname>Голубцова</surname><given-names>Е. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>engolubtsova@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tomilov</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Томилов</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Department of Urology and Surgical Andrology, Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia, Moscow</institution></aff><aff><institution xml:lang="ru">Кафедра урологии и хирургической андрологии ГБОУ ДПО РМАПО Минздрава России, Москва</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2014-09-30" publication-format="electronic"><day>30</day><month>09</month><year>2014</year></pub-date><volume>10</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>95</fpage><lpage>99</lpage><history><date date-type="received" iso-8601-date="2014-11-09"><day>09</day><month>11</month><year>2014</year></date><date date-type="accepted" iso-8601-date="2014-11-09"><day>09</day><month>11</month><year>2014</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/387">https://oncourology.abvpress.ru/oncur/article/view/387</self-uri><abstract xml:lang="en"><p>In spite of its existing standards, the treatment of patients with progressive prostate cancer (PC) remains a matter of debate. Ensuring that the patients have good quality of life is also relevant. The paper describes a clinical case of a patient with progressive PC after hormone therapy, brachytherapy, salvage prostatectomy, enucleation of the testicular parenchyma, and salvage lymphadenectomy. A phallic prosthesis and an artificial urinary sphincter have been implanted to improve quality of life. The results of preoperative examination and the technological features of surgical interventions are given.</p></abstract><trans-abstract xml:lang="ru"><p>Несмотря на существующие стандарты, лечение пациентов с прогрессирующим раком предстательной железы (РПЖ) остается предметом дискуссий. Не менее актуальны и вопросы обеспечения достойного качества жизни. В статье представлено клиническое наблюдение пациента с прогрессирующим РПЖ, перенесшего гормональную терапию, брахитерапию, спасительную простатэктомию, энуклеацию паренхимы яичек, спасительную лимфаденэктомию. С целью улучшения качества жизни была выполнена имплантация фаллопротеза и искусственного мочевого сфинктера. Приводятся результаты предоперационного обследования и технические особенности оперативных вмешательств.</p></trans-abstract><kwd-group xml:lang="en"><kwd>salvage prostatectomy</kwd><kwd>phallic prosthesis</kwd><kwd>artificial urinary sphincter</kwd><kwd>salvage lymphadenectomy</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>спасительная простатэктомия</kwd><kwd>фаллопротез</kwd><kwd>искусственный мочевой сфинктер</kwd><kwd>спасительная лимфаденэктомия</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Center M.M., Jemal A., Lortet-Tieulent J. et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012;61:1079–92.</mixed-citation><mixed-citation xml:lang="ru">Center M.M., Jemal A., Lortet-Tieulent J. et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012;61:1079–92.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Cooperberg M.R., Broering J.M., Carroll P.R. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010;28: 1117–23.</mixed-citation><mixed-citation xml:lang="ru">Cooperberg M.R., Broering J.M., Carroll P.R. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010;28: 1117–23.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Rosenbaum E., Partin A., Eisenberger M.A. Biochemical relapse after primary treatment for prostate cancer: studies on natural history and therapeutic considerations. J Natl Compr Canc Netw 2004;2: 249–56.</mixed-citation><mixed-citation xml:lang="ru">Rosenbaum E., Partin A., Eisenberger M.A. Biochemical relapse after primary treatment for prostate cancer: studies on natural history and therapeutic considerations. J Natl Compr Canc Netw 2004;2: 249–56.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Stephenson A.J., Scardino P.T., Bianco F.J., Eastham J.A. Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy. Curr Treat Options Oncol 2004;5:357–65.</mixed-citation><mixed-citation xml:lang="ru">Stephenson A.J., Scardino P.T., Bianco F.J., Eastham J.A. Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy. Curr Treat Options Oncol 2004;5:357–65.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Chade D.C., Shariat S.F., Cronin A.M. et al. Salvage radical prostatectomy for radiationrecurrent prostate cancer: a multi-institutional collaboration. Eur Urol 2011;60:205–10.</mixed-citation><mixed-citation xml:lang="ru">Chade D.C., Shariat S.F., Cronin A.M. et al. Salvage radical prostatectomy for radiationrecurrent prostate cancer: a multi-institutional collaboration. Eur Urol 2011;60:205–10.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Chade D.C., Eastham J., Graefen M. et al. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol 2012;61:961–71.</mixed-citation><mixed-citation xml:lang="ru">Chade D.C., Eastham J., Graefen M. et al. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol 2012;61:961–71.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Falcone M., Rolle L., Ceruti C. et al. Prospective analysis of the surgical outcomes and patients' satisfaction rate after the AMS Spectra penile prosthesis implantation.Urology 2013;82(2):373–6.</mixed-citation><mixed-citation xml:lang="ru">Falcone M., Rolle L., Ceruti C. et al. Prospective analysis of the surgical outcomes and patients' satisfaction rate after the AMS Spectra penile prosthesis implantation.Urology 2013;82(2):373–6.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Picchio M., Briganti A., Fanti S. et al. The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. Eur Urol 2011;59: 51–60.</mixed-citation><mixed-citation xml:lang="ru">Picchio M., Briganti A., Fanti S. et al. The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. Eur Urol 2011;59: 51–60.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Scattoni V., Picchio M., Suardi N. et al. Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy. Eur Urol 2007;52:423–9.</mixed-citation><mixed-citation xml:lang="ru">Scattoni V., Picchio M., Suardi N. et al. Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy. Eur Urol 2007;52:423–9.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Rigatti P., Suardi N., Briganti A. et al. Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C] choline positron emission tomography/ computed tomography. Eur Urol 2011;60: 935–43.</mixed-citation><mixed-citation xml:lang="ru">Rigatti P., Suardi N., Briganti A. et al. Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C] choline positron emission tomography/ computed tomography. Eur Urol 2011;60: 935–43.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Van der Aa А., Drake M.J., Kasyan G.R. et al. The Artificial Urinary Sphincter After a Quarter of a Century: a critical systematic review of its use in male non-neurogenic incontinence. Eur Urol 2013;63: 681–9.</mixed-citation><mixed-citation xml:lang="ru">Van der Aa А., Drake M.J., Kasyan G.R. et al. The Artificial Urinary Sphincter After a Quarter of a Century: a critical systematic review of its use in male non-neurogenic incontinence. Eur Urol 2013;63: 681–9.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
